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Incidence and mortality rates are considered as a guideline for planning public health strategies and allocating resources. We apply
functional data analysis techniques to model age-specific brain cancer mortality trend and forecast entire age-specific functions
using exponential smoothing state-space models. The age-specific mortality curves are decomposed using principal component
analysis and fit functional time series model with basis functions. Nonparametric smoothing methods are used to mitigate the
existing randomness in the observed data. We use functional time series model on age-specific brain cancer mortality rates and
forecast mortality curves with prediction intervals using exponential smoothing state-space model. We also present a disparity of
brain cancer mortality rates among the age groups together with the rate of change of mortality rates. The data were obtained from
the Surveillance, Epidemiology and End Results (SEER) program of the United States. The brain cancer mortality rates, classified
under International Classification Disease code ICD-O-3, were extracted from SEER∗Stat software.

1. Introduction
Functional data analysis is about the analysis of information
on curves or functions [1]. Functional data is multivariate
data with an ordering on the dimensions Muller, 2006. In
the present study we are interested in the distribution of
functions means, covariances, and relationships of functions
to certain responses and other functions. One of the major
advantages of functional data analysis is a strong possibility of
using rate of change or derivatives of curves. In this study we
combine methodologies from functional data analysis, nonparametric statistics, and time series forecasting. There has
been an intense research in this area during the last decade
[2]. In addition, future mortality rates are of great interests
for strategic planner and the insurance industry. Accurate
forecasting can be a strong indicator for allocating budget,
planning, and policy making. Here, we develop forecasting
models for crude mortality rates of malignant primary brain
and central nervous system cancer of the United States for the
study period of 1969–2008.
The age-specific mortality rates can play a significant role
for the allocation of resources for brain tumor control and

evaluations. Primary purpose of this study is to apply functional data analysis techniques to model age-specific brain
cancer mortality time trends and forecast entire age-specific
mortality function using state-space-approach [3]. Our aim
in the present study is to answer the following questions:
(i) to capture the subtle pattern of variation in mortality,
(ii) to find the prediction interval of the forecast,
(iii) to find a flexible model so that it could incorporate
the covariates such as screening and treatment effects
into the analysis.
However, there are some limitation in functional time
series forecasting model. It only incorporates year of death
(calendar period) and fails to consider year of birth (cohort)
effects. The calendar period incidence and mortality trend
can reveal the effects of new medical interventions but fail to
reflect changes in risk factors such as screening and radiation
therapy.
Currently, most of the forecasting models are based on
age-period-cohort methods. These methods are structured to
estimate the mortality rates of breast cancer [4], prostate

2

Advances in Epidemiology

cancer [5], and cervical cancer [6, 7]. These methods are
basically regression models with mortality or incidence rates
as outcome variables using Poisson error distribution with log
link function. The most common problem in these models
is nonidentifiability of parameters, very strong parametric
assumptions, and sensitivity of projections and lack of
inclusion of most recent changes in cohort effects. Most
importantly, a limitation of these studies is that none of them
forecast mortality rates with age-related changes.
The linear extrapolation and nonlinear Poisson distribution models are discussed in [8, 9] whereas a Bayesian ageperiod-cohort model with autoregressive smoothing of each
of age, period, and cohort components is studied such that
the resulting projections are estimated from current and past
trends of the data in [4]. Lee and Carter (LC) [10] method
is one of the most influential methods in demographic forecasting. This is perhaps the most cited paper by demographic
researchers. LC proposed a long term forecasting method
to extrapolate mortality rates and applied it to forecast US
mortality rates for the year 2065.
There has been numerous extensions of LC method, some
of the extensions and modifications of LC method can be
found in [11]; Renshaw and Haberman (2003) [12], and the
applications of LC method in fertility forecasting can found in
Lee [13]. The method proposed by Lee and Carter in 1992 has
become the leading statistical model of mortality/forecasting
in the demographic literature [14], Deaton and Paxson, 2004
[15]. It was used as a benchmark for recent Census Bureau
population forecasts [16], and two US social security technical
advisory panels recommended its use, or the use of a method
consistent with it [11].
A comprehensive discussion of the patterns of mortality
rates for then G 7 countries is presented by Tuljapurkar et al.
[14] using LC method. The LC model predicted 1-to-4year higher life expectancy than official projections in the
industrial nations, with larger differences for Japan.
There are numerous uncertainties which affect the mortality rates; however a probabilistically sound forecasting
method, like LC method, is particularly useful to address the
long term funding problems of public pension and insurance
for increasingly ageing population in the industrial world.

2. Functional Data Analysis (FDA) Model
2.1. An Overview. The Lee Carter model for age-specific
mortality rates is given by
ln (𝑚𝑥,𝑡 ) = 𝑎𝑥 + 𝑏𝑥 𝑘𝑡 + 𝜖𝑥,𝑡 ,

(1)

where 𝑎𝑥 is general age shape of age-specific mortality rates,
𝑏𝑥 represents the tendency of mortality at age 𝑥, and 𝑘𝑡 is
the time varying index. Equation (1) is a linear model of an
unobserved period-specific intensity index, with parameter
depending on age (LC 1992). LC model uses singular value
decomposition (SVD) method for exact least square fit; however, a simple linear regression method can also approximate
the parameters. LC incorporates a random walk with drift for
the time series formed by 𝑘𝑡 , which is expressed as
𝑘𝑡 = 𝑘𝑡−1 + 𝑐 + 𝑒𝑡 ,

(2)

where 𝑐 is the drift term, 𝑘 is forecast to decline linearly with
increment of 𝑐, and 𝑒𝑡 are permanently incorporated in the
trajectory [11]. The standard error of 𝑐 could be used for the
detailed measure of uncertainty in forecasting 𝑘.
Generalization. The Hyndman-Ullah [3] approach is a generalization of Lee and Carter (LC 1992) method.
Our primary goal is to find functional forecasting model
for mortality rates of brain and central nervous system tumor
in the United States. The proposed forecasting model is
developed in the realm of functional data [1] for modeling
log mortality rates. To develop the functional data, we invoke
the nonparametric smoothing methods to mitigate the existing randomness in the observed information. In addition,
the problems related to age groups and issues of outlying
years are reasonably addressed by using functional principal component [1, 3]. The observed data is smoothed and
principal component analysis is applied after smoothing the
observed data.
The forecasting methodology by Hyndman-Ullah is a
generalization of Lee and Carter method. This approach
uses functional data analysis techniques and treats the agespecific mortality curves as the units of analysis rather than
the discrete observations [3]. In practice, functional data are
usually observed and recorded discretely as 𝑛 pairs (𝑡𝑗 , 𝑦𝑗 ),
and 𝑦𝑗 is a snapshot of the function at time 𝑡𝑗 , possibly blurred
by measurement error [1]. Generalized Lee Carter method
models the mortality rates as a continuous function of age and
captures the subtle variation between years. In addition the
smoothness of the data reduces the observational error and
forecast the entire function with prediction intervals [3].
In the following section we discuss the use of more flexible
[3] method to model the brain cancer mortality rates which
uses multiple functions to capture the changes in rates.
2.2. FDA Model for Mortality Data. Let 𝑚𝑡 (𝑥) denote the
mortality rate for midpoint of age group 𝑥 and year 𝑡, 𝑡 =
1, . . . , 𝑛. We model the log mortality,
𝑦𝑡 (𝑡) = log [𝑚𝑡 (𝑥)] ,

(3)

and assume that there are underlying functions 𝑓𝑡 (𝑥) that we
are observing with error [17]. The mortality rates as a smooth
function of age can be expressed as
𝑦𝑡 (𝑥𝑖 ) = 𝑓𝑡 (𝑥𝑖 ) + 𝜎𝑡 (𝑥𝑖 ) 𝜀𝑡,𝑖 ,

(4)

where 𝑥𝑖 is the center of age group 𝑖 (𝑖 = 1, . . . , 𝑝), 𝜀𝑡,𝑖 is
an independent and identically distributed standard normal
random variable, and 𝜎𝑡 (𝑥𝑖 ) allows the amount of noise to
vary with the age 𝑥. After developing functions of the given
mortality rates, we fit the model
𝐾

𝑓𝑡 (𝑥) = 𝜇 (𝑥) + ∑ 𝛽𝑡,𝑘 𝜙𝑘 (𝑥) + 𝑒𝑡 (𝑥) ,

(5)

𝑘=1

where 𝜇(𝑥) is the mean log mortality rate across years, 𝜙𝑘 (𝑥)
is a set of orthogonal basis functions, and 𝑒𝑡 (𝑥) is the model
error which is assumed to be serially uncorrelated [17].
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The mean log mortality rates 𝜇(𝑥) are estimated by using
penalized regression splines (Wood, 2000) [18]. The pairs
(𝛽𝑡,𝑘 , 𝜙𝑘 (𝑥) for 𝑘 = 1, 2, . . . , 𝐾) are estimated by decomposing the data into principal components, whereas 𝑒𝑡 (𝑥)
is the difference between spline curve and fitted curve
from the model. We wish to estimate the optimal set of 𝐾
orthogonal basis functions. The optimal orthogonal basis
function 𝜙𝑘 (𝑥) is obtained via principal components (see
Ramsay and Silverman, 2005, pages 151-152). Specifically, for
a given 𝐾, we want to find the basis functions {𝜙𝑘 (𝑥)} which
minimizes the mean integrated squared error:
MISE =

1 𝑛
∑ ∫ 𝑒2 (𝑥) 𝑑𝑥.
𝑛 𝑡=1 𝑡

(6)

where 𝜎̂𝜇2 (𝑥) is the variance obtained using the smoothing
method. The forecast variance is given by
𝑢𝑛+ℎ,𝑘 = Var (𝛽𝑛+ℎ,𝑘|𝛽1,𝑘 ,...,𝛽𝑛,𝑘 ) ,

(10)

]𝑘 (𝑥): sum of square of residuals, 𝜎𝜇2 (𝑥): variance of the
̂
smooth estimate 𝜇(𝑥),
𝜎2 (𝑥) is estimated by assuming binomial distribution of 𝑚𝑡 (𝑥), and ](𝑥) is the mean of 𝑒̂𝑡2 (𝑥) for
each 𝑥.
We evaluate the accuracy of the mortality forecast by
computing the mean integrated squared forecasting error
(MISFE) defined as
MISFE (ℎ) =

𝑛
2
1
∑ ∫ [𝑦𝑡+ℎ (𝑥) − 𝑓̂𝑡,ℎ (𝑥)] 𝑑𝑥,
𝑛 − 𝑚 + 1 𝑡=𝑚

This is achieved using functional principal components
(FPC) decomposition, [19], applied to the curves {𝑓𝑡 (𝑥)}
which provides the least number of basis functions, and
explores the coefficients which are uncorrelated with each
other.

where 𝑚 is the minimum number of observations used in
fitting the model.

2.3. Forecasting. Equations (4) and (5) together yield

3. Data

𝑦𝑡 (𝑥𝑖 ) = ln [𝑚𝑥,𝑡 ]
𝐾

= 𝜇 (𝑥) + ∑ 𝛽𝑡,𝑘 𝜙𝑘 (𝑥) + 𝑒𝑡 (𝑥) + 𝜎𝑡 (𝑥𝑖 ) 𝜀𝑡,𝑖 .

(7)

𝑘=1

̂ 𝑘, ℎ) denote the ℎ-step forecast of 𝛽
Let 𝛽(𝑛,
𝑛+ℎ,𝑘 and let
̂
𝑓𝑛,ℎ (𝑥) denote the ℎ-step ahead forecast of 𝑓𝑛+ℎ (𝑥). Then,
𝐾

𝑓̂𝑛,ℎ (𝑥) = 𝜇̂ (𝑥) + ∑ 𝛽̂ (𝑛, 𝑘, ℎ) 𝜙̂𝑘 (𝑥) .

(8)

𝑘=1

To forecast the coefficients from (8) we use state-space model
for exponential smoothing. The exponential smoothing
method provides a statistical framework for automatic forecasting [19]. This forecast then multiplied with estimated
basis function to obtain the forecast of the entire function. In
addition, exponential smoothing techniques also provide
prediction intervals for the forecast by incorporating variance
of error terms [20]. Forecast from exponential smoothing
methods is estimated recursively where recent observations
are given more weight than historical data. This method
accommodates additive and multiplicative trend with automatic model selection for the given time series [17].
The state-space models provide a convenient and powerful framework for analyzing sequential data (see Harvey 1989)
[21]. Many mortality data sets require extrapolation, as data
has a time dimension. The state-space model can be used to
calculate smooth feature or signals and associated standard
errors provided the model is of the state-space form.
The sum of the variances of all individual terms is the
forecast variance [3]:
Var [𝑦̂𝑛+ℎ,𝑘 (𝑥)]
𝐾

= 𝜎̂𝜇2 (𝑥) + ∑ 𝑢𝑛+ℎ,𝑘 𝜙̂𝑘2 (𝑥) + ] (𝑥) + 𝜎𝑡2 (𝑥) ,
𝑘=1

(9)

(11)

An estimated 69,720 (10% increment from 2010) new cases
of primary nonmalignant and malignant brain and central
nervous system tumors are expected to be diagnosed in the
United States in 2013 [22]. This caused 13,700 (5.5% increment
from 2009) deaths because of the primary malignant brain
and central nervous system tumors in the United States in
2012. It is estimated that 24,620 men and women (13,630
men and 10,990 women) will be diagnosed and 13,140 (4.26%
increment from 2010) men and women are estimated to be
deceased of brain and other nervous system cancer in 2013.
Males and females have a 0.7% and 0.6% lifetime risk of being
diagnosed with a primary malignant brain/central nervous
system tumor. These projections are of major public health
interest. However, their interpretation may be complex
because of the effect of screening, risk factors, and accessibility of effective treatments.
Crude mortality rates per 100,000 persons based on
the 2000 standard US population were extracted using the
SEER∗Stat 7.0.5 software of the Surveillance Epidemiology
and End Results program, National Cancer Institute Institutes. We are using 416,480 (229,467 males and 187,013
females) malignant Brain cancer patients, where 381,238 are
whites, 24,336 are African Americans, and 4,891 are others
(American Indian/AK Native, Asian/Pacific Islander, 1969–
2008).
The mortality rates were at their highest from 1885 to 1995.
After 2000 we observed that the overall rates are leveling off or
declining. From 2003–2008, the median age at death for cancer of the brain and other nervous system was 64 years of age.
Approximately 4.2% died under age of 20; 3.8% died between
20 and 34; 7.1% between 35 and 44; 14.9% between 45 and 54;
21.8% between 55 and 64; 22.2% between 65 and 74; 19.6%
between 75 and 84; 6.3% died at 85+ years of age. For the
first part of our study, we use annual crude mortality rates in
the United states from 1969 to 2008 in 5-year age groups (01–
04, 05–09,. . .,80–84, 85+).
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Figure 1: Age-specific brain cancer mortality by age group among
total males (1969–2008). In the figure 49 represents the age group
45–49, 64 represents the age group 60–64, and 89 represent the age
group above 85.
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Figure 2: Age-specific brain cancer mortality by age group among
total females (1969–2008). In the figure 49 represents the age group
45–49, 64 represents the age group 60–64, and 89 represent the age
group above 85.

4. Results
For this study we obtained the data from the Surveillance,
Epidemiology and End Results (SEER) program of National
Cancer Institute in the United States [23]. Specifically,
mortality data were obtained from the National Center for
Health Statistics (NCHS) available on the SEER∗Stat
database. Annual age-specific brain cancer mortality data are
designated by ICD 8 & 9 (1979–1998) code 174 and ICD 10
(1999+) codes C70 and C71. The data available is about
different racial subgroups since 1969 in nineteen year age
groups: 01–04, 05–09, 10–14, 15–19, 20–24, 25–29, 30–34,
35–39, 40–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74,
75–79, 80–84, and 85+.
Figure 1 displays brain cancer mortality rates in US male
by age group for the period of 1969–2007. We observe that the
mortality rates for ages below 40 years show no obvious trend;
for the same period the pattern of mortality rates for ages
more than 40 exhibited significant variation of mortality rates
for the elderly. The graph shows the brain cancer mortality
rates among males between 45 and 65 years declined slowly
throughout the study period. The pattern for the elderly
(aged 65 and above) population is clearly increasing from
1969 to 2000 and started declining after 2000. However,
mortality rates for the population subgroups between 45–65
show slightly decreasing pattern. The mortality rates for the
age groups 80–84 and 85+ are very unstable and difficult to
interpret because of the limited availability of data.
In Figure 2, we present the age-specific mortality rates
with respect to the year of decease for the female subpopulation. The trends in mortality rates do not show any visible
pattern for the age groups less than 40 years. The rates for the

age groups 50–54, 55–59, and 60–64 show decrease in mortality during the whole period of study. Overall, the mortality
rate for males is lower than that of female but the age-specific
mortality rates show no obvious difference between the
rates. Figure 3 displays the age-specific mortality rates with
respect to age for the women subpopulation for brain cancer
mortality rates during the entire period of study, 1969–2008.
The graph depicts similar variation of hazard rates as for the
male subpopulation. These rates are notably unstable for the
young (less than 20 years), monotonically increasing for middle age population (between 20 and 67), and decreasing with
with strong instability for the elderly (67 and above). In general, mortality rates are directly proportional to age, and for
every year, highest mortality rates are observed in the age
groups 80–84, 85 and above; this is true for both male and
female subpopulation.
In Figure 4, we present the mortality rates of the male
subpopulation for the entire period of study. The male brain
cancer mortality rates are higher than female in magnitude
but show similar pattern for different clusters of the population. Figure 4 clearly indicates three different patterns of mortality rates: first, unstable and decreasing mortality rates for
patients below 20; second, reasonably stable pattern of mortality rates for middle aged population subgroups (ages 20–
65); and third, significantly increasing and very erratic behavior of mortality rates for the elderly (ages 65 and above). Three
different patterns of mortality rates by age are present for
the total population different subgroups of population as well.
However, this behavior of mortality rates is more apparent in
male population.
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Figure 3: Age-specific brain cancer mortality with respect to age for
females subgroup of the population (1969–2008).
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Figure 4: Brain cancer mortality rates as a function of age for male
subpopulation (1969–2008).

In the next section, we develop smooth functions of
mortality rates as a function of age for different population
subgroups. The smooth (or interpolated) functions are developed for brain and CNS tumor mortality rates; these smooth
functions are used to find principal components to measure
the variability of the data. Penalized regression splines are
used to find smooth functional curve with a monotonicity
constraint. The curves are monotonically increasing for age
greater than 20. The smoothness of the curves is controlled
by a smoothing parameter 𝜆 based on Wood [18]. The term
functional refers to the intrinsic structure of the data under
the assumption that there exists a function of 𝑥 giving rise to
the observed data [1].
For the given period of study 1969–2008, we assume the
existence of the function of age with respect to the mortality
rates plus observational error. The observation errors can be
mistakes in collecting or recording the data. The observed
data are smoothed using penalized regression spline with
penalty 𝜆 = 4. We assume that 𝑓𝑡 (𝑥) is monotonic for 𝑥 > 20
years. It is reasonable to assume monotonicity in mortality
data (the older you are, the more likely you are to die). The
data are technically smooth after 20 years and there are no
outlying years present. We also analysed the same data using
linear interpolation as well; final results were not significantly
different from the results obtained from regression splines.
We would like to develop a mathematically independent set
of basis functions 𝜙𝑘 which can be approximated by linear
combination of 𝐾 of these functions. The basis system is not
specifically defined by the fixed number of parameters but
rather itself is a parameter that we choose as per the nature
of the data. One of the primary criteria to choose basis is to
test the behavior of their derivatives; some of the bases that
give reasonable fit may end up with poor derivative estimates.
We choose a model with 𝐾 = 6 basis functions. The number
of basis functions is chosen by minimizing the mean square

error (MSE) and mean integrated squared forecasting error
(MISFE) [17, 19]. Six basis functions ended up with minimum
mean square error (MSE) together with mean integrated
squared error and mean integrated squared forecasting error
(MISFE). No additional basis function contributed in further
reduction of MISFE. The estimated coefficients are presented
in the bottom of Figure 5.
The functional regression model with six basis functions
explained 98.8% of the variability of the data for total
observation (both male and female) during the period of
study in the United States. The proportion of variation
explained by each basis function in the decreasing order of
their magnitude is 92.0%, 4.8%, 0.6%, 0.6%, 0.6%, 0.3%, and
0.5% for 𝑘 = 1, . . . , 6, respectively. The mean square error
(MSE) for the variability 0.00082 and the integrated squared
error (ISE) is given by 0.07217. For females, the first six
basis functions in the functional model explain 87.6%, 5.5%,
1.8%, 1.1%, 0.8%, and 0.7% of the total variation of female
mortality rates with mean squared error 0.00183 and integrated squared error 0.16050, while 88.6%, 4.8%, 1.7%, 1.2%,
0.7%, and 0.6% of the total variability of mortality rates are
explained for male population with MSE = 0.00153 and ISE =
0.13532. The overall goodness of fit was assessed by using
residuals of fitted mortality model using image plots. The
plots showed no lack of fit. We also checked autocorrelation
in the observational error, 𝜖𝑡 (𝑥𝑖 ), for each 𝑥𝑖 and in the one
step forecast error for various age groups. The autocorrelation
was either insignificant or sufficiently small. In addition, we
evaluated the accuracy of mortality forecasts by using MISFE
where we set 𝑚 = 10 as minimum number of observations
used in fitting the model. That is, we fit the model up to time
𝑡 and predict next 𝑛 periods to obtain MISFE.
The optimal orthogonal basis functions are computed
from principal component decomposition. We want to find a
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Figure 5: The functional model for brain cancer mortality in the USA. Top line: the mean function and first six basis functions. Bottom line:
the coefficients associated with each of the basis functions.
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set of exactly 𝐾 orthogonal functions 𝜙𝑘 so that the expansion
of each curve in terms of these basis functions approximates
the curve as closely as possible (see Ramsay and Silverman,
2005, pages 151-152). Figure 5 explores the first six basis
functions together with the corresponding coefficients. The
basis functions and the time series coefficients model the
overall variability of the mortality rates. The first basis
function (𝜙1 ) models the higher age groups (around 80 years),
as the score is the largest in negative direction; second basis
function (𝜙2 ) models the middle age (20–65); the third and
fourth (𝜙3 and 𝜙4 ) basis functions represent the infants and
people under 20 years of age respectfully. The fifth and sixth
(𝜙5 and 𝜙6 ) are relatively complex to explain and we are
not attempting to explain these functions because of their
unpredictable variability.
The plots of time series coefficients, Figure 5, depict a
continuously increasing pattern before 1990, while the rates
show a declining pattern during the decade of 1990–2000.
The first time series coefficients represent decreasing trend
but since the basis function has negative sign, the older ages
(around 80 years) have been increasing during the study
period and it can also be observed from Figure 3. The second
time series is first increasing till 1990 and then decreasing
which corresponds to the age group 20–40 years. More
specifically, the mortality rates are increasing for the age
groups more than 65, slightly decreasing for the population
with the age between 40 and 65, and the rates are leveled off
for younger population. The variability of mortality rates for
the patients more than 80 years is remarkably high, which is
numerically important and less explained by the basis functions. The erratic death rates for the elderly may be because
of the measurement error than due to behavior of the rates.
Similar study by Coale and Kisker [24] showed that the
mortality data are highly susceptible and fraught with various
types of measurement problems. It is more reasonable to
have detail and separate study of patients above 80 years; we
excluded the mortality rates for the age groups 80–84 and 85+
in the later part of our study.
The forecast of the brain cancer mortality rates is calculated by multiplying the time series coefficients with the basis
functions. Figure 6 shows 10-year forecast of mortality rates
for male and female together during the period of study. We
observe that the brain and CNS cancer mortality rates are
expected to increase with respect to age. One-year and tenyear forecast show a declining pattern of mortality rates for
brain and CNS tumor patients of all the age groups. A declining pattern of mortality rates is observed for the ages less
than 60. However, the declining pattern of mortality rates is
inverted for the elderly.
The difference between the mortality rates is remarkably
higher in the age groups more than 75 years. Average
difference of mortality rates in the age groups 75–79, 80–84,
85–89, and 89+ is 0.05 per 100,000 per year. We observe that
the average mortality rates of a person of 62 years of age is
almost 10 times higher than that of a person of 32 years of age.
Long term forecast shows that the rates are predicted to
decline relatively slowly in the next decade. The mortality
rates for the total US population are expected to decrease by
1.58% for the age group of 0–4 years, and at the same time
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Figure 6: Forecast of age-specific mortality of total brain and central
nervous system cancer patients in the United States for 2009 and
2018, with 80% confidence intervals.

rates are expected to increase by 5.5% for the age group of 80–
84. Specifically, the mortality rates are predicted to increase
for all the persons above 65 years of age. For total US population with age less than or equal to 65 the rates are predicted
to decrease linearly at the rate of 0.0145 per 100,0000 per
year (𝑃 value < 0.05). We also observed that 20th percentile
of difference in mortality rates between 2009 and 2018 is
0.501 per 100,000 pear year; 50th percentile is 0.796; and
99 percentile of the difference between mortality rates is 1.57
per 100,000 per year.
In Figure 7, we present one-year and ten-year prediction
intervals for male and female populations. The mortality rates
are expected to increase, (comparing with 2009) for both
the gender by 0.17 (0.37%) persons per 100,000 by 2018.
For the same period the mortality rates for males and females
separately are expected to increase by 0.33 (0.78%) and 0.11
(0.19%) persons per 100,000 by 2018. This may be because
of erratically higher mortality rates of elderly population.
However, age-specific forecast for 2009 and 2018 shows
slower rate of decline in female mortality rates in comparison
to the male population. The average increment in mortality
rates is 0.33 persons per 100,000 and 0.84 persons per 100000
for males and females aged below 65 years, respectively. We
also observed that the mortality rate for the age groups more
than 65 is increasing in higher rate than other age groups. The
average rate of increase in mortality rates for the elderly is
1.23 (5%) and 0.44 (0.38%) persons per 100000 for males and
females, respectively (see Table 1). The mortality rates for the
elderly population are subject to error because of availability
of information and erratic behavior in the mortality rates. Lee
and Carter (1991) [10] also mentioned the unreliability of
age groups 85+. In contrast, after clustering the ages into
three groups, 0–19 (young adults), 20–64 (middle age), and
65 and above (elderly), we observe that the mortality rates for
younger population are estimated to decrease with the highest declining rate followed by the middle aged population.
In Table 1, we present one-year and ten-year forecast of
the mortality rates. The average decrease (from 2009 to 2018)
in mortality rates for male and female subpopulation is 1.6
and 1.41 persons per 100,000. The variability of the mortality
rates for different age groups is clearly noticeable. Despite the
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Figure 7: Forecast of age-specific mortality of brain and central nervous system cancer in the United States for 2009 and 2018 for male and
female subpopulation with 80% confidence intervals.
Table 1: Forecast and 80% prediction intervals of mortality rates of total US patients of brain and CNS tumors for 2009 and 2018.
Age
2
7
12
17
22
27
32
37
42
47
52
57
62
67
72
77
82
87

Total
2009
2018
Mean
80% PI
Mean
80% PI
0.62 0.55 0.70 0.61 0.53 0.70
0.88 0.80 0.97 0.87 0.78 0.97
0.63 0.56 0.71 0.62 0.55 0.71
0.48 0.44 0.53 0.48 0.42 0.54
0.53 0.48 0.58 0.52 0.47 0.59
0.73 0.66 0.80 0.72 0.64 0.81
1.10
1.01 1.20
1.09 0.97 1.22
1.63
1.51
1.76
1.62 1.46 1.79
2.49 2.33 2.66 2.47 2.27 2.70
3.70 3.45 3.97 3.67 3.36 4.01
5.48 5.17 5.81
5.45 5.02 5.91
8.00 7.62 8.41
7.95
7.40 8.54
10.84 10.30 11.41 10.80 10.05 11.60
13.88 13.20 14.61 13.91 12.91 14.99
17.14 16.05 18.31 17.40 15.70 19.28
19.22 17.62 20.96 19.77 17.10 22.86
19.94 17.30 22.98 21.05 16.60 26.69
17.44 14.63 20.78 18.70 13.89 25.19

Male
Female
2009
2018
2009
2018
Mean
80% PI
Mean
80% PI
Mean
80% PI
Mean
80% PI
0.66 0.56 0.79 0.65 0.54 0.78 0.57 0.49 0.66 0.56 0.47 0.67
0.87 0.76 0.99 0.85 0.74 0.98 0.88 0.78 1.00 0.88 0.77 1.00
0.63 0.55 0.74 0.62 0.53 0.74 0.62 0.53 0.71 0.61 0.52 0.71
0.53 0.46 0.61 0.53 0.45 0.62 0.42 0.37 0.49 0.42 0.35 0.49
0.62 0.53 0.72 0.60 0.51 0.71 0.42 0.34 0.52 0.42 0.33 0.53
0.86 0.75 0.99 0.86 0.73 1.00 0.53 0.45 0.63 0.54 0.43 0.66
1.33
1.20 1.47
1.32
1.16 1.50 0.84 0.73 0.98 0.84 0.70 1.00
2.00 1.83
2.19
1.99 1.78 2.22 1.24
1.11
1.39
1.23 1.07 1.42
3.10 2.84 3.39 3.08 2.78 3.42 1.90
1.71 2.10 1.88 1.66 2.12
4.58 4.20 4.99 4.54 4.10 5.03 2.87 2.61 3.15 2.85 2.54 3.18
6.73 6.25 7.25 6.69 6.10 7.33
4.29 3.94 4.66 4.26 3.82 4.75
9.73
9.13 10.38 9.69 8.93 10.50 6.29 5.84 6.78 6.26 5.67 6.91
13.25 12.50 14.06 13.27 12.33 14.27 8.56 7.88 9.30 8.55 7.68 9.53
16.83 15.71 18.02 17.01 15.59 18.56 11.13 10.32 12.00 11.17 10.10 12.37
20.64 19.15 22.26 21.21 19.11 23.54 14.18 12.93 15.54 14.37 12.62 16.36
23.81 21.65 26.19 24.87 21.76 28.42 15.59 13.90 17.48 15.98 13.31 19.19
24.69 20.94 29.11 26.64 21.17 33.51 16.66 14.10 19.69 17.35 13.12 22.95
23.30 19.00 28.57 25.72 19.24 34.38 14.52 11.82 17.82 15.38 10.89 21.73

fact that brain and CNS cancer is one of the most vulnerable
cancer for the younger population, the mortality rates are
declining faster than middle aged and elderly population. In a
separate study of mortality rates for the age groups 0–19 and
20–64 we report smaller MSE as well ISE in comparison to
the models with age groups together (see Appendices A and B
for forecast of the mortality rates for age groups 0–19 and 20–
65).

In Tables 2 and 3, we present predicted change in
percentage of mortality rates between 2009 and 2018. Table 2
shows the mortality rates are increasing for the elderly age
group whereas the case is inverted for other two age groups.
In addition, we can expect that 50% or more younger patients
will see 5.14% reduction of mortality rates in the younger subpopulation in 2018 whereas 50% of the middle aged patient
(20–65) are predicted to have 3.35% reduction in mortality
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Table 2: Summary of differences (in %) in mortality rates between
2009 and 2018 for all patients. Differences are noted with − and +
indicating decreasing and increasing pattern of mortality.

Median
Maximum
Minimum

Before clustering
0–19
20–64
65+
−1.22
−0.63
+2.89
−1.57
−0.86
+7.26
−0.94
−0.11
+0.11

After clustering
0–19
20–64
−5.14
3.35
−6.03
−7.77
−4.7
−0.459

Table 3: Summary of differences (in %) in mortality rates between
2009 and 2018 for male and female subpopulation. Differences are
noted with − and + indicating decreasing and increasing pattern of
mortality.
Male
Median
Maximum
Minimum

0–19
−5.5
−6.18
−5.1

20–64
−2.5
−9.76
+0.29

0–19
−4.8
−5.8
−2.5

Female
20–64
−4.6
−6.01
−1.7

rates. These percentage changes will be lower if we include
the elderly subpopulation (65 and above) in the study.
In Table 3, we present differences in percentage of mortality rates after clustering by sex. The mortality rates are
expected to decrease for younger and middle age subpopulation. Interestingly, the rates are predicted to decrease by
higher percentage for younger male subpopulation whereas
the female middle aged subpopulation are predicted to have
higher decrease than their male counterparts.

5. Discussion
In this study of brain cancer mortality in the United states,
we present an application of new forecasting method [3] in
brain cancer mortality rates. The mortality-age relationship
is modeled by using basis expansion of the data which highlights important trends during the period of study. We report
that the mortality rates are predicted to decrease continuously
for all the brain and CNS patients of age groups 0–19
and 20–64 (predicted to decrease by 3.5% in 2018). Higher
mortality rates are estimated for the elderly (65 and above)
but these rates are heavily influenced by low sample size and
higher fluctuation of mortality rates of the subject age group.
We also observed that male population possess relatively
homogenous pattern of mortality rates in comparison to
female subpopulation. In addition, males have consistently
higher mortality rates than female mortality rates.
Our model predicts a decreasing pattern of mortality in
brain cancer in the United States for the next decade. We
also report relatively small change in mortality for the age
group 20–65, while the rates are expected to increase for
patients more than 65 years of age. Interestingly, we observed
a higher decline in mortality rates for the younger population
subgroup. Advancements in treatment have significantly
helped to increase survival rates for children with brain
tumors [25].

There are three age groups with distinct mortality patterns: young adults (0–19); the middle aged (20–64); and the
elderly (65 and above). Predicted rates are reported to be
decreased by higher percentage after studying the clusters
separately. Before clustering, for young adults, the median of
percentage difference between mortality rates is predicted to
be lowered by 1.22% in 2018. Similarly, after clustering, the
rates are predicted to decrease by 5.14% in 2018. It is also
reported that about 75% of children survive at least 5 years
after being diagnosed with a brain tumor [26]. Nevertheless,
many childhood brain tumor survivors are at risk for longterm neurological complications.
The functional form of the data is able to capture the
subtle variations in mortality rates; thus the models and
forecasts both have notable strength demographic forecasting
[17]. The other studies in modeling mortality and fertility forecasting also have acknowledged the implication of
functional data analysis approach in modeling all causes of
mortality rates [11, 27]. Functional data analysis method on
fertility and mortality data achieves better forecasting results
than other approach to mortality forecasting [3]. Moreover,
FDA technique allows the variation of mortality rates so that
for different ages mortality declines or increases at different
rates.
FDA techniques are getting popularity since last decade,
especially after the publication of a pioneering book in FDA
by Ramsay and Silverman in 2005. This technique has number of strengths in modeling high dimensional and missing
data. For a detailed review of FDA and its application in the
different fields of study see [2]. Functional analysis techniques
make no parametric assumptions about age or period of
effects; variation of mortality rates is presented with respect
to time so that for different ages the fluctuation of rates
can be modeled. Also, functional models are free from the
strong parametric assumptions of error variations and do not
assume linear dependency between the variables age, period,
and cohort. To the best of our knowledge, no other studies
modeled or forecast the brain cancer mortality rates with age
as functional covariates over time.

Appendices
A. Appendix A
See Table 4.

B. Appendix B
See Table 5.
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Table 4: Age- and gender-specific prediction of brain cancer mortality rates of young adults for the years 2009 and 2018. In the first table,
prediction is made for all the patients under study. In the second table, perdition of mortality rates is made separately for young adults (0–19
years). Prediction of mortality rates show higher decreasing rate if analysis is done after clustering the data by age groups.
(a)

Age
2
7
12
17

Total
2009
2018
Mean
80% PI
Mean
80% PI
0.62 0.55 0.70 0.61 0.53 0.70
0.88 0.80 0.97 0.87 0.78 0.97
0.63 0.56 0.71 0.62 0.55 0.71
0.48 0.44 0.53 0.48 0.42 0.54

Male
2009
2018
Mean
80% PI
Mean
80% PI
0.66 0.56 0.79 0.65 0.54 0.78
0.87 0.76 0.99 0.85 0.74 0.98
0.63 0.55 0.74 0.62 0.53 0.74
0.53 0.46 0.61
0.53 0.45 0.62

Female
2009
2018
Mean
80% PI
Mean
80% PI
0.57 0.49 0.66 0.56 0.47 0.67
0.88 0.78 1.00 0.88 0.77 1.00
0.62 0.53 0.71
0.61 0.52 0.71
0.42 0.37 0.49 0.42 0.35 0.49

(b)

Age
2
7
12
17

Total
2009
2018
Mean
80% PI
Mean
80% PI
0.63 0.56 0.71 0.59 0.52 0.67
0.84 0.76 0.92 0.80 0.73 0.89
0.61 0.55 0.68 0.58 0.52 0.65
0.50 0.45 0.55 0.47 0.42 0.52

Male
2009
2018
Mean
80% PI
Mean
80% PI
0.66 0.56 0.79 0.62 0.52 0.74
0.81
0.71 0.93 0.77 0.67 0.88
0.64 0.55 0.74 0.60 0.52 0.70
0.57 0.49 0.66 0.54 0.46 0.62

Female
2009
2018
Mean
80% PI
Mean
80% PI
0.59
0.51 0.69 0.56 0.48 0.65
0.86 0.76 0.97 0.84 0.74 0.94
0.56 0.49 0.65 0.54 0.47 0.62
0.42 0.36 0.48 0.39 0.34 0.46

Table 5: Age- and gender-specific prediction of brain cancer mortality rates of young adults for the years 2009 and 2018. In the first table,
prediction is made for all the patients under study. In the second table, perdition of mortality rates is made separately for middle age (20–64
years) subpopulation. Prediction of mortality rates show higher decreasing rate if analysis is done after clustering the data by age groups.
(a)

Age
22
27
32
37
42
47
52
57
62

Total
Male
Female
2009
2018
2009
2018
2009
2018
Mean
80% PI
Mean
80% PI
Mean
80% PI
Mean
80% PI
Mean
80% PI
Mean
80% PI
0.53 0.48 0.58 0.52 0.47 0.59 0.62 0.53 0.72 0.60 0.51 0.71
0.42 0.34 0.52 0.42 0.33 0.53
0.73 0.66 0.80 0.72 0.64 0.81 0.86 0.75 0.99 0.86 0.73 1.00
0.53 0.45 0.63 0.54 0.43 0.66
1.10
1.01 1.20 1.09
0.97 1.22
1.33
1.20 1.47
1.32
1.16 1.50
0.84 0.73 0.98 0.84 0.70 1.00
1.63
1.51 1.76 1.62
1.46 1.79 2.00
1.83
2.19
1.99
1.78 2.22
1.24
1.11 1.39 1.23 1.07 1.42
2.49 2.33 2.66 2.47 2.27 2.70 3.10
2.84 3.39
3.08 2.78 3.42
1.90 1.71 2.10 1.88 1.66 2.12
3.70 3.45 3.97 3.67 3.36 4.01 4.58 4.20 4.99 4.54 4.10 5.03
2.87 2.61 3.15 2.85 2.54 3.18
5.48
5.17 5.81 5.45 5.02 5.91
6.73 6.25 7.25
6.69 6.10 7.33
4.29 3.94 4.66 4.26 3.82 4.75
8.00
7.62 8.41 7.95
7.40 8.54 9.73
9.13 10.38 9.69 8.93 10.50 6.29 5.84 6.78 6.26 5.67 6.91
10.84 10.30 11.41 10.80 10.05 11.60 13.25 12.50 14.06 13.27 12.33 14.27 8.56 7.88 9.30 8.55 7.68 9.53
(b)

Age
22
27
32
37
42
47
52
57
62

Total
Male
Female
2009
2018
2009
2018
2009
2018
Mean
80% PI
Mean
80% PI
Mean
80% PI
Mean
80% PI
Mean
80% PI
Mean
80% PI
0.50 0.45 0.55 0.46 0.40 0.52 0.57 0.50 0.67 0.52 0.44 0.61
0.39 0.32 0.48 0.36 0.29 0.45
0.71 0.65 0.78 0.68 0.62 0.76 0.83 0.73 0.95 0.82
0.71 0.95 0.55 0.47 0.66 0.52 0.44 0.62
1.08 0.99 1.18
1.04 0.94 1.15
1.41
1.28 1.56
1.32
1.18
1.47
0.82 0.71 0.94 0.77 0.66 0.90
1.57
1.46 1.69
1.52
1.39 1.66 2.02
1.85 2.20
1.90
1.72
2.10
1.21 1.08 1.35
1.15
1.02 1.30
2.41
2.25 2.58 2.33
2.15 2.52 3.03 2.78 3.31
2.99 2.72 3.29
1.81
1.62 2.02 1.73
1.53 1.95
3.56 3.32 3.82 3.44
3.17 3.73 4.50 4.14 4.90 4.38 3.99 4.81
2.77 2.51 3.06 2.65 2.37 2.95
5.36 5.06 5.67 5.19 4.84 5.57 6.59
6.12 7.09
6.47 5.95 7.03
4.23 3.88 4.60 4.05 3.68 4.45
7.89
7.50 8.30 7.72
7.27 8.21 9.79
9.17 10.46 9.50 8.84 10.21 6.33 5.86 6.84 6.13 5.63 6.68
11.00 10.35 11.69 10.95 10.25 11.70 13.45 12.65 14.30 13.49 12.64 14.40 8.87 8.13 9.68 8.71 7.95 9.55
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